Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines

Cell Mol Life Sci. 2023 Oct 11;80(11):323. doi: 10.1007/s00018-023-04922-5.

Abstract

Background: The functional contribution of non-myocyte cardiac cells, such as inflammatory cells, in the setup of heart failure in response to doxorubicin (Dox) is recently becoming of growing interest.

Objectives: The study aims to evaluate the role of macrophages in cardiac damage elicited by Dox treatment.

Methods: C57BL/6 mice were treated with one intraperitoneal injection of Dox (20 mg/kg) and followed up for 5 days by cardiac ultrasounds (CUS), histological, and flow cytometry evaluations. We also tested the impact of Dox in macrophage-depleted mice. Rat cardiomyoblasts were directly treated with Dox (D-Dox) or with a conditioned medium from cultured murine macrophages treated with Dox (M-Dox).

Results: In response to Dox, macrophage infiltration preceded cardiac damage. Macrophage depletion prevents Dox-induced damage, suggesting a key role of these cells in promoting cardiotoxicity. To evaluate the crosstalk between macrophages and cardiac cells in response to DOX, we compared the effects of D-Dox and M-Dox in vitro. Cell vitality was lower in cardiomyoblasts and apoptosis was higher in response to M-Dox compared with D-Dox. These events were linked to p53-induced mitochondria morphology, function, and autophagy alterations. We identify a mechanistic role of catecholamines released by Dox-activated macrophages that lead to mitochondrial apoptosis of cardiac cells through β-AR stimulation.

Conclusions: Our data indicate that crosstalk between macrophages and cardiac cells participates in cardiac damage in response to Dox.

Keywords: Catecholamines; Doxorubicin; Macrophages; Mitochondria; Mitophagy; p53; β-AR.

MeSH terms

  • Animals
  • Apoptosis
  • Catecholamines* / metabolism
  • Doxorubicin* / adverse effects
  • Macrophages
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / metabolism
  • Oxidative Stress
  • Rats

Substances

  • Catecholamines
  • Doxorubicin